Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Endo’s excellent altered presentations
14 October 2025

Endo’s excellent altered presentations

Image Credit: Investors | Endo Announcement  Endo, a full-fledged subsidiary of Mallinckrodt plc, showcased a total of nine presentations based on XIAFLEX (collagenase clostridium histolyticum, injection 0.9 mg) and Peyronie’s disease or PD. The presentation will be projected during t...

Novo integrates Akero’s experimental drug under a billion-dollar deal
14 October 2025

Novo integrates Akero’s experimental drug under a billion-dollar deal

Image Credit: ET Pharma Announcement  Novo Nordisk will acquire Akero Therapeutics for $5.2 billion, marking Novo as the latest major pharmaceutical company to enter a rapidly growing area in liver disease that has seen numerous high-profile deals emerge so far. With this acquisition, Novo ...

UST’s billions of deals in AI ruling healthcare innovation
14 October 2025

UST’s billions of deals in AI ruling healthcare innovation

Image Credit: Forebes Announcement  The UST, a leading technology and AI-dedicated solutions company, has cracked a deal with three significant healthcare companies worth USD 2 billion. With this, UST will strengthen its position as a valued, trustworthy partner to a few of the region's adv...

Suki’s nursing association, in alignment with the coalition of health systems
13 October 2025

Suki’s nursing association, in alignment with the coalition of health systems

Image Credit: Suki AI Announcement  Suki, the popular face of artificial intelligence (AI) for healthcare, has made new efforts targeted at the administrative hassles faced by nurses globally. This involves the introduction of an inaugural nursing association with the popular health systems...

Apogee’s declared proposed guaranteed public offering
13 October 2025

Apogee’s declared proposed guaranteed public offering

  Image Credit: Yahoo Finance Announcement  Apogee Therapeutics Inc., a leading clinical-level biotechnology company accelerating optimization, novel biologics with standing ability for excellent profiles in the immunology and inflammatory (I and I) sector, has declared an underwritte...

Sanofi enters the realm of radiopharma with a competition to Novartis
13 October 2025

Sanofi enters the realm of radiopharma with a competition to Novartis

Image Credit: Medcity News Announcement  Sanofi’s Orano breakthrough radioligand therapy, Alphamedix, has successfully passed the efficacy test, meeting an excellent endpoint. Involving a cumulative response rate in its mid-stage study of ALPHAMEDIX-02. On the other side, Novartis, an...

Medtronic’s vitalflow ECMO expansion in Europe
10 October 2025

Medtronic’s vitalflow ECMO expansion in Europe

Image Credit: MassDevice Announcement  Medtronic, a leading global medtech company, has expanded its VitalFlow One-System ECMO solution with the official launch in Europe. The VitalFlow extracorporeal membrane oxygenation (ECMO) system, integrated in the cardiac surgery portfolio, was a win...

Cigna introduces a new healthcare solution
10 October 2025

Cigna introduces a new healthcare solution

Announcement  Cigna Healthcare is a leading health benefits business of the Cigna Group, has introduced a new healthcare solution focusing on Japanese expatriate employees or individuals working in the UK. The product (healthcare solution platform) provides a ‘doorkeeper’ alterna...

nChroma to receive approval for abstracts at the meeting of the AASLD
10 October 2025

nChroma to receive approval for abstracts at the meeting of the AASLD

Announcement  The nChroma Bio, a leading genetic medicines company developing in vivo delivery of unique cargoes to address the limitations of the previous therapies, has received approval for its three abstracts, as well as the poster of distinction that will be officially confirmed at the ...

Huvepharma and Checkerspot entered a commercial-purpose partnership contract
10 October 2025

Huvepharma and Checkerspot entered a commercial-purpose partnership contract

Image Credit: Vegconomist Announcement  Checkerspot, a certified B corporation and a leading biotechnology company that works on renewable oils and fats via the fermentation of microalgae, and Huvepharma, a known leading fermentation and biopharmaceutical company, have entered a commercial-...